Fortrea, a global provider of clinical development and patient access solutions to the life sciences industry, has selected Cognizant as its technology transformation provider.
With Cognizant, Fortrea aims to continue delivering solutions to its pharmaceutical, biotechnology and medical device customers and to the patients those customers serve.
Over this four-year-long partnership, Cognizant hopes to transform Fortrea’s global technology environment and bring the speed and agility necessary for deploying the next-generation hybrid cloud. These technologies will empower Fortrea and enable a seamless digital experience with agility and efficiency across various touchpoints.
Explore related questions
Leveraging Cognizant’s services, Fortrea’s data and analytical capabilities will be enhanced to set new standards in the CRO industry and drive the modernization required to support the company’s global operations. Fortrea will also benefit from Cognizant’s robust life sciences and healthcare technology experience to address the evolving needs of its customers.
Prasad Sankaran, EVP, software and platform engineering at Cognizant, said: “Cognizant is proud to partner with Fortrea as they leverage technology to build a world-class culture of excellence that benefits customers, patients, employees and shareholders.
“With our deep domain expertise in clinical trial platforms, medical administration automation and secure collaboration, we can help Fortrea fortify its position as an independent, best-in-class digital, global Contract Research Organization.”
Alejandro Martinez Galindo, chief information officer of Fortrea, said: “[This] announcement reflects Fortrea’s renewed organizational agility following our spin-off.
“We are selectively investing in clinical applications and platforms that give us and our customers an advantage in the race to bring life-changing treatments to patients faster. As we build the infrastructure that’s essential to supporting these platforms and quickly delivering the insights our customers rely on, we have the opportunity to be ‘born digital.’ Our new modern ecosystem will be designed to speed decision-making with innovation in clinical development. Cognizant’s deep expertise will help make our vision a reality.”
